(Q24244839)

English

Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia (English)

0 references

1 reference

4

0 references

author name string

Hany George El-Sayeh

series ordinal

1

0 references

Joao Paolo Lyra da Silva

series ordinal

2

0 references

John Rathbone

series ordinal

3

0 references

publication date

25 January 2006

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

A controlled trial of amantadine hydrochloride and neuroleptics in the treatment of tardive dyskinesia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Tetrabenazine and movement disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Metoclopramide and Haloperidol in Tardive Dyskinesia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

The effects of papaverine in tardive dyskinesia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Statistics notes. Trials randomised in clusters

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

The unit of analysis error in studies about physicians' patient care behavior

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Issues in the meta-analysis of cluster randomized trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Receptor sensitivity modification (RSM) — A new paradigm for the potential treatment of some hormonal and transmitter disturbances

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

The current status of tardive dyskinesia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Miscellaneous treatments for neuroleptic-induced tardive dyskinesia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

21 January 2018

Metoprolol versus propranolol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Naloxone, tardive dyskinesia, and endogenous beta-endorphin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Tiapride in the treatment of tardive dyskinesia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000458.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD000458.PUB2

0 references

PubMed ID

16437424

0 references

(Q24244839)

Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)